Evidence map›Paper›PMID 39673326›Full record

ArticleJournal of occupational health2024

Estimating the probability of multiple incidences of the same cancer type in a single workplace.

Sintaroo Watanabe, Kota Fukai, Masayuki Tatemichi

Abstract read
In one paragraph

Article in Journal of occupational health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sintaroo WatanabeSafety & Health Group, Japan Marine United Corporation Kure Shipyard, Kure, 737-0027 Japan.
Kota FukaiDepartment of Preventive Medicine, Tokai University School of Medicine, Isehara, 259-1193 Japan.ORCID 0000-0002-8319-8467
Masayuki TatemichiDepartment of Preventive Medicine, Tokai University School of Medicine, Isehara, 259-1193 Japan.

Funding

Ministry of Health, Labour and Welfare 230601-01
6 · The paper itself

Abstract

objectivesThis study aimed to estimate the probability of observing 2 cases of the same cancer type in a workplace with 300 employees, to help investigation of occupational cancer.

methodsWe assumed a workplace where chemicals are handled, employing 300 males aged 15 to 64, with an age distribution standardized to Japan's population from 2016 to 2019. Using national cancer statistics for newly diagnosed cases among males in this age range and period, we calculated the expected number of cancer cases for the workplace over a 1- and 10-year period. We computed standardized incidence ratios (SIRs) for 2 instances of the same cancer type within these time frames and estimated the time required for the SIR to reach 2.0 and its lower 95% CI limit (LL) to reach 1.0.

resultsThe SIR for any cancer type exceeded 10 and was significantly high when 2 cases occurred within 1 year. Over 10 years, the SIR remained significantly high in some cancer types. The observation periods required for SIR to reach 2.0 and LL to reach 1.0 for any cancer type were at least 5.4 and at least 1.7 years, respectively.

conclusionsConsidering that over 99% of Japanese workplaces employ fewer than 300 people, the likelihood of observing the same cancer type within 1 year is low. This study enhances our understanding of occupational cancer incidence and supports the integration of such data into prevention strategies.

Indexed as

NeoplasmsWorkplaceAdolescentAdultHumansIncidenceJapanMaleMiddle AgedOccupational DiseasesOccupational ExposureProbabilityYoung Adultcancer epidemiologychemical exposureoccupational cancerstandardized incidence ratios

Identifiers

PMID39673326
PMCPMC11662353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.